Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice
暂无分享,去创建一个
Tony Wyss-Coray | L. Mucke | R. Mahley | T. Wyss-Coray | I. Tesseur | Manuel Buttini | Yadong Huang | F. M. Harris | W. Brecht | Qin Xu | Lennart Mucke | Yadong Huang | Shengjun Chang | Shengjun Chang | Robert W Mahley | Walter J Brecht | Faith M Harris | Ina Tesseur | Gui-Qiu Yu | Qin Xu | Jo Dee Fish | Manuel Buttini | Gui-qiu Yu | Jo Dee Fish
[1] G. Getz,et al. Isoform-specific binding of apolipoprotein E to beta-amyloid. , 1994, The Journal of biological chemistry.
[2] P. Barter,et al. Plasma Lipids and Their Role in Disease , 1999 .
[3] B. Tycko,et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. , 2002, Archives of neurology.
[4] A. Delacourte,et al. Synthesis and Regulation of Apolipoprotein E during the Differentiation of Human Neuronal Precursor NT2/D1 Cells into Postmitotic Neurons , 2000, Experimental Neurology.
[5] T. Uchihara,et al. Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction , 2003, Stroke.
[6] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[7] Patrick R Hof,et al. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. , 2002, Progress in brain research.
[8] Joachim Herz,et al. Apolipoprotein E receptors: linking brain development and alzheimer's disease , 2000, Nature Reviews Neuroscience.
[9] T Vogel,et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.
[10] A. Roses,et al. Apolipoprotein E Expression by Neurons Surviving Excitotoxic Stress , 1999, Neurobiology of Disease.
[11] S. Schmidt,et al. Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular β-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and Aβ Production* , 2003, Journal of Biological Chemistry.
[12] S. Lovestone,et al. Truncated apoE forms tangle-like structures in a neuronal cell line , 2002, Neuroreport.
[13] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[14] A. Matsunaga,et al. "Association of apolipoprotein E allele !e4 with late-onset familial and sporadic Alzheimer's disease": Comment. , 1994 .
[15] A. Haase,et al. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.
[16] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[17] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] L. Mucke,et al. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo , 1997, Neuroscience.
[19] R. Mahley,et al. Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells , 2004, Journal of Biological Chemistry.
[20] R. Mahley,et al. Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells* , 2002, The Journal of Biological Chemistry.
[21] Lars Bäckman,et al. Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.
[22] E Brisch,et al. The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.
[23] Matthias Orth,et al. Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.
[24] Yaakov Stern,et al. The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 1998 .
[25] J. Gilbert,et al. Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.
[26] D. Selkoe. The molecular pathology of Alzheimer's disease , 1991, Neuron.
[27] Joakim Bjorkdahl. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. , 2000 .
[28] B. Hyman,et al. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.
[29] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[30] D. Bennett,et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.
[31] J. Gilbert,et al. Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice , 1999, Neurobiology of Disease.
[32] L. Mucke,et al. Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid β Peptides But Not on Plaque Formation , 2002, The Journal of Neuroscience.
[33] J. Taylor,et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.
[34] I. Tesseur,et al. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.
[35] D. Borchelt,et al. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. , 2001, Human molecular genetics.
[36] H. Arai,et al. Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain. , 1996, Neuroreport.
[37] I. Tesseur,et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. , 2000, The American journal of pathology.
[38] L. Mucke,et al. Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits , 2002, The Journal of Neuroscience.
[39] J. Gilbert,et al. Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.
[40] S. Spinler,et al. Lipoprotein(A): Physiologic Function, Association with Atherosclerosis, and Effects of Lipid-Lowering Drug Therapy , 1994, The Annals of pharmacotherapy.
[41] H. Brewer,et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.
[42] C. Finch,et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.
[43] A D Roses,et al. Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.
[44] O. Steward,et al. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Mahley,et al. Apolipoprotein E and Human Disease , 1999 .
[46] L. Mucke,et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Mahley,et al. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.
[48] P. Armati,et al. Synthesis and processing of apolipoprotein E in human brain cultures , 2001, Glia.
[49] R. Nixon,et al. Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.
[50] A. von Eckardstein,et al. Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia* , 1998, The Journal of Biological Chemistry.
[51] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[52] R. Depalma. Plasma lipids and their role in disease , 2000 .
[53] A. Delacourte,et al. ApoE Synthesis in Human Neuroblastoma Cells , 1997, Neurobiology of Disease.
[54] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[56] R. Mahley,et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[58] Lars Bertram,et al. New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.
[59] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Poirier,et al. Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[61] D. Holtzman,et al. Behavioral Phenotyping of GFAP-ApoE3 and -ApoE4 Transgenic Mice: ApoE4 Mice Show Profound Working Memory Impairments in the Absence of Alzheimer's-like Neuropathology , 2001, Experimental Neurology.
[62] L. Mucke,et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Crowther. Tau protein and paired helical filaments of Alzheimer's disease , 1993 .
[65] A. Roses,et al. Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study , 1994, Journal of neuropathology and experimental neurology.
[66] S. Paul,et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[67] M. Mattson,et al. Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity , 1999, The Journal of Neuroscience.
[68] E. Otomo,et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.
[69] M. Tolar,et al. Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated , 1997, The Journal of Neuroscience.
[70] G. Getz,et al. Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.